MINISTOP Plus Program for Pre-school Children With Overweight and Obesity

June 26, 2024 updated by: Christine Delisle Nyström, Karolinska Institutet

MINISTOP Plus Program for Pre-school Children With Overweight and Obesity: A Pilot Randomized Controlled Trial

The Mobile-based intervention intended to stop obesity in preschoolers (MINISTOP) program has been developed to be a comprehensive digital support program for all children irrespective of weight status. However, a one size fits all approach may not be sufficient as some families may require extra support through in-person activities to achieve the required lifestyle behaviour change in order to attain and maintain a healthy weight. Therefore, the aims of this pilot randomized controlled trial are to evaluate the efficacy and feasibility of the MINISTOP Plus Program in pre-school children with overweight and obesity on: (i) children's BMI z-scores; (ii) intake of fruit and vegetables, sweet and savoury snacks, and sweet drinks; (iii) time spent in different physical activity intensities; (iv) screen time; and (v) parental self-efficacy.

Study Overview

Status

Withdrawn

Conditions

Study Type

Interventional

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Huddinge, Sweden, 141 83
        • Department of Biosciences and Nutrition

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

2 years to 5 years (Child)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • 2 to 5 year old children with overweight and obesity residing in the municipality of Kungsbacka.

Exclusion Criteria:

  • If a child has a disease or disorder that affects body size or feeding.
  • Children who have a parent suffering from a serious physical or psychological disease making the study too demanding for the family.
  • Children from families who will not be able to understand the app content, i.e., those who do not speak Swedish, English, Arabic, or Somali

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: MINISTOP app
Receives the MINISTOP app for 12-months.
The MINISTOP app is a behavioural change program aiming to promote healthier diet and physical activity behaviours in pre-school children. The program consists of features such as information, monitoring and feedback (dietary variables, physical activity, and screen time) and it is built around 13 themes. The participants will have access to the app for 12-months.
Experimental: MINISTOP Plus Program
Receives the MINISTOP app for 12-months and receives Community Group Mini.
Consists of the MINISTOP app and the Community Group Mini. The Community Group Mini consists of group activities to promote physical activity for both children and parents. The Community Group Mini will meet once per week in different playgrounds and nature reserves and will be organized by a trained group leader.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Body mass index
Time Frame: At the end of the intervention which is 12-months after baseline
Body weight divided by height squared
At the end of the intervention which is 12-months after baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Intake of key dietary indicators as assessed by a questionnaire.
Time Frame: At the end of the intervention which is 12-months after baseline.
Intake of fruits, vegetables, sweet snacks, savoury snacks, and sweet drinks (grams/day)
At the end of the intervention which is 12-months after baseline.
Physical activity assessed using an accelerometer
Time Frame: At the end of the intervention which is 12-months after baseline
Time spent in different physical activity intensities, i.e., sedentary, light, moderate, vigourous, and moderate-to-vigorous physical activity (minutes/day)
At the end of the intervention which is 12-months after baseline
Screen time as assessed by a questionnaire
Time Frame: At the end of the intervention which is 12-months after baseline
Number of minutes per day spent in front of a screen
At the end of the intervention which is 12-months after baseline
Self-efficacy self-efficacy for promoting healthy dietary and physical activity behaviours in their children's
Time Frame: At the end of the intervention which is 12-months after baseline
Questionnaire to parents
At the end of the intervention which is 12-months after baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Christine Delisle Nyström, PhD, Karolinska Institutet

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

December 1, 2024

Primary Completion (Estimated)

December 31, 2025

Study Completion (Estimated)

September 30, 2026

Study Registration Dates

First Submitted

September 1, 2022

First Submitted That Met QC Criteria

September 1, 2022

First Posted (Actual)

September 6, 2022

Study Record Updates

Last Update Posted (Actual)

June 28, 2024

Last Update Submitted That Met QC Criteria

June 26, 2024

Last Verified

June 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 2022-02956-01

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity, Childhood

Clinical Trials on MINISTOP app

Subscribe